Non-small Cell Lung Cancer Drug Market in South Korea

Targeted Therapies Offer Hope in Midst of Low Survival Rates and Increasing Incidence

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service presents an overview and analysis of the non-small cell lung cancer drug market in South Korea from 2010 to 2017. It provides an analysis of the patient load, typical treatment regimens, clinical trial statistics by phase, and treatment challenges. Along with this coverage, the research service also outlines market drivers and restraints, Market Engineering measurements, and market trends. The research service ends with a market analysis, which includes the competitive structure, and industry megatrends.

Table of Contents

Non-small Cell Lung Cancer Drug Market in South Korea, Overview of the Non-small Cell Lung Cancer Drug Market in South KoreaAnalysis of the Non-small Cell Lung Cancer Drug MarketNon-small Cell Lung Cancer Drug Market Analysis




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.